Browse All
Displaying 1 - 1 of 1
Author:Mozaffar, Tahseen Schoser, Benedikt Kishnani, Priya Bratkovic, Drago Clemens, Paula R. Goker-Alpan, Ozlem Ming, Xue Roberts, Mark Sivakumar, Kumaraswamy Van Der Ploeg, Ans Goldman, Mitchell Wright, Jacquelyn Holdbrook, Fred Jain, Vipul Sitaraman, Sheela Wasfi, Yasmine Byrne, Barry
Session Name:S48: Therapeutics for Muscle Disease
Topic:Neuromuscular and Clinical Neurophysiology (EMG)
Program Number:S48.007
Author Institution:University of California, Irvine, Irvine, CA Friedrich-Baur-Institut, Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany Duke University Medical Center, Durham, NC PARC Research Clinic, Royal Adelaide Hospital, Adelaide, SA, Australia Department of Neurology, University of Pittsburgh School of Medicine, Division Chief, Neurology, Medical Service Line, VA Pittsburgh Healthcare System, Pittsburgh, PA Lysosomal and Rare Disorders Research and Treatment Center, Fairfax, VA Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ Salford Royal NHS Foundation Trust, Salford, United Kingdom Neuromuscular Clinic and Research Center, Phoenix, AZ Erasmus MC University Medical Center, Rotterdam, Netherlands Amicus Therapeutics, Inc., Philadelphia, PA University of Florida, Gainesville, FL
